Patient experiences with outpatient opioid use disorder treatment before and during COVID-19: results from a survey of Medicaid members.

Sarah J. Marks, Huyen Pham, Neil McCray, Jennifer Palazzolo, Ashley Harrell, Jason Lowe, Chethan Bachireddy, Lauren Guerra, Peter J. Cunningham, Andrew J Barnes
{"title":"Patient experiences with outpatient opioid use disorder treatment before and during COVID-19: results from a survey of Medicaid members.","authors":"Sarah J. Marks, Huyen Pham, Neil McCray, Jennifer Palazzolo, Ashley Harrell, Jason Lowe, Chethan Bachireddy, Lauren Guerra, Peter J. Cunningham, Andrew J Barnes","doi":"10.1080/00952990.2024.2328543","DOIUrl":null,"url":null,"abstract":"Background: Payers are increasingly interested in quality improvement for opioid use disorder (OUD) treatment, including incorporating patient experiences. Medicaid is the largest payer for OUD treatment, yet we know little about the treatment benefits Medicaid members report, how these vary across members, or changed with the COVID-19 pandemic.Objective: To examine Medicaid members' report of outpatient treatment benefits, employment, and housing outcomes before and during the pandemic.Methods: A representative sample of 1,032 Virginia Medicaid members (52% women) receiving OUD treatment completed a survey of treatment benefits, health status and social needs. A reported treatment benefit index was created based on seven self-reported items. Multivariable linear regression models, pooled and stratified by time (pre-COVID-19/COVID-19), assessed member characteristics associated with reported treatment benefit, employment and housing outcomes.Results: Members reported strong treatment benefit (mean: 21.8 [SD: 5.9] out of 28 points) and improvements in employment (2.4 [1.3] out of 5) and housing (2.8 [1.2] out of 5). After adjustment, mental distress (regression coefficient: -3.00 [95% CI:-3.97;-2.03]), polysubstance use (-1.25 [-1.99;-0.51]), and food insecurity (-1.00 [-1.71;-0.29]), were associated with decreased benefits from treatment. During COVID-19, justice-involved individuals reported decreased benefits (-2.17 [-3.54; -0.80]) compared to before the pandemic (-0.09 [-1.4-;1.24] p < .05).Conclusions: Medicaid members receiving outpatient OUD treatment reported positive treatment benefits, and housing and employment outcomes. However, those with comorbid health and social conditions often benefited the least. As payers move toward quality improvement and value-based purchasing initiatives, collecting and integrating patient reported outcomes into quality metrics is critical.","PeriodicalId":501667,"journal":{"name":"The American Journal of Drug and Alcohol Abuse","volume":"22 8","pages":"1-14"},"PeriodicalIF":0.0000,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American Journal of Drug and Alcohol Abuse","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/00952990.2024.2328543","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Payers are increasingly interested in quality improvement for opioid use disorder (OUD) treatment, including incorporating patient experiences. Medicaid is the largest payer for OUD treatment, yet we know little about the treatment benefits Medicaid members report, how these vary across members, or changed with the COVID-19 pandemic.Objective: To examine Medicaid members' report of outpatient treatment benefits, employment, and housing outcomes before and during the pandemic.Methods: A representative sample of 1,032 Virginia Medicaid members (52% women) receiving OUD treatment completed a survey of treatment benefits, health status and social needs. A reported treatment benefit index was created based on seven self-reported items. Multivariable linear regression models, pooled and stratified by time (pre-COVID-19/COVID-19), assessed member characteristics associated with reported treatment benefit, employment and housing outcomes.Results: Members reported strong treatment benefit (mean: 21.8 [SD: 5.9] out of 28 points) and improvements in employment (2.4 [1.3] out of 5) and housing (2.8 [1.2] out of 5). After adjustment, mental distress (regression coefficient: -3.00 [95% CI:-3.97;-2.03]), polysubstance use (-1.25 [-1.99;-0.51]), and food insecurity (-1.00 [-1.71;-0.29]), were associated with decreased benefits from treatment. During COVID-19, justice-involved individuals reported decreased benefits (-2.17 [-3.54; -0.80]) compared to before the pandemic (-0.09 [-1.4-;1.24] p < .05).Conclusions: Medicaid members receiving outpatient OUD treatment reported positive treatment benefits, and housing and employment outcomes. However, those with comorbid health and social conditions often benefited the least. As payers move toward quality improvement and value-based purchasing initiatives, collecting and integrating patient reported outcomes into quality metrics is critical.
患者在 COVID-19 之前和期间接受阿片类药物使用障碍门诊治疗的经历:医疗补助计划成员的调查结果。
背景:付款人对提高阿片类药物使用障碍(OUD)治疗质量的兴趣与日俱增,包括将患者的经历纳入其中。医疗补助计划(Medicaid)是阿片类药物使用障碍(OUD)治疗的最大支付方,但我们对医疗补助计划成员所报告的治疗福利、这些福利在不同成员之间的差异,以及 COVID-19 大流行所带来的变化知之甚少:研究医疗补助计划成员在大流行之前和期间对门诊治疗福利、就业和住房结果的报告:对接受 OUD 治疗的 1,032 名弗吉尼亚州医疗补助计划成员(52% 为女性)进行了代表性抽样调查,调查内容包括治疗福利、健康状况和社会需求。根据七个自我报告的项目创建了一个报告的治疗福利指数。多变量线性回归模型按时间(COVID-19 前/COVID-19)进行汇总和分层,评估了与报告的治疗益处、就业和住房结果相关的成员特征:成员们报告了很好的治疗效果(平均值:21.8 [SD: 5.9],满分为 28 分)以及就业(2.4 [1.3] ,满分为 5 分)和住房(2.8 [1.2] ,满分为 5 分)方面的改善。经过调整后,精神压力(回归系数:-3.00 [95% CI:-3.97;-2.03])、多种药物使用(-1.25 [-1.99;-0.51])和食品不安全(-1.00 [-1.71;-0.29])与治疗收益的减少有关。在 COVID-19 期间,与大流行之前(-0.09 [-1.4-;1.24] p < .05)相比,参与司法程序的个人报告的受益减少(-2.17 [-3.54; -0.80]):结论:接受 OUD 门诊治疗的医疗补助成员报告了积极的治疗效果、住房和就业情况。然而,那些合并有健康和社会问题的人往往受益最少。随着付款人向质量改进和基于价值的采购倡议迈进,收集患者报告的结果并将其纳入质量指标至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信